Abstract:Background: This study aimed to investigate the feasibility, effectiveness, and safety of pancreatic duct stenting in managing acute biliary pancreatitis (ABP) necessitating endoscopic retrograde cholangiopancreatography (ERCP). It further aimed to provide valuable insights for subsequent clinical diagnosis and treatment. Methods: This research employs an observational retrospective case-control study design, encompassing patients with ABP who underwent ERCP at the hepatobiliary surgery department of the General Hospital of Ningxia Medical University between August 1, 2018, and December 31, 2020. A total of 229 cases were screened based on inclusion and exclusion criteria. Regardless of ABP severity, patients were categorized into the stent group (141) and the non-stent group (88). Changes in blood amylase (Amy), lipase (LIP), leukocyte count (WBC), total bilirubin (TBIL), alanine aminotransferase (ALT), hematocrit (HCT), and creatinine (CR) were compared between the two groups. Moreover, variables such as recovery time for oral feeding, hospitalization duration, hospitalization costs, local complications, systemic complications, and new organ failure were recorded to assess the therapeutic effect of pancreatic duct stenting. Results: No significant differences were observed in gender, age, Acute Physiology and Chronic Health Evaluation (APACHE) II score, ABP severity grade, organ failure (OF), cholangitis, or biliary obstruction between the pancreatic stent and non-stent groups (P > 0.05). There was no significant difference in the incidence of complications related to acute pancreatitis between the two groups (P > 0.05). The median fasting and hospitalization times of patients in the stent group were significantly shorter than those in the non-stent group (P < 0.05). No significant differences between the groups were observed in hospitalization costs and in-hospital mortality (P > 0.05). There were no significant variations in white blood cell (WBC) count, TBIL, ALT, and creatinine (Cr) at admission, 72 h, and in the differences between the two groups (P > 0.05). The levels of Amy at admission and 72 h in the stent group were significantly higher than those in the non-stent group (P < 0.05). The differences in LIP and HCT in the stent group were considerably higher than in the non-stent group (P < 0.05). Although no significant differences were observed in mean Amy and LIP between the two groups (P > 0.05), the mean 72-h HCT in the stent group was 38.39% (95% confidence interval [CI] 37.82%-38.96%) was lower than that in the non-stent group (39.44%, 95% CI 38.70-40.17%) (P < 0.05). Conclusion: In the stent group, feeding time and hospital stay were significantly shorter than those in the non-stent group. No significant differences were observed between the two groups in the incidence of complications and mortality. The HCT value decreased more rapidly in the stent group. Early pancreatic stent implantation demonstrated the potential to shorten the eating and hospitalization duration of patients with ABP, facilitating their prompt recovery. Trial registration: This study was registered as a single-center, retrospective case series (ChiCTR1800019734) at chictr.org.cn.

Clinical value of indwelling cutting with guidewire in difficult intubation of pancreatic duct for chronic pancreatitis

Can wire-guided cannulation reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis? A meta-analysis of randomized controlled trials.

Applicafion of individual selection strategy for pancreatico-digestive anastomosis after pancreaticoduodenectomy

The Prognostic Value of External Vs Internal Pancreatic Duct Stents in CR-POPF after Pancreaticoduodenectomy: A Systematic Review and Meta-analysis

How to Perform Total Laparoscopic Duodenum-Preserving Pancreatic Head Resection Safely and Efficiently with Innovative Techniques

Application of Endoscopic Pancreatic Duct Stent Insertion in Chronic Pancreatitis: A Report of 30 Cases

A retrospective analysis of the clinical efficacy of pancreatic duct stent implantation in the management of acute biliary pancreatitis requiring ERCP

Efficacy of Pancreatic Duct Stenting Prior to Laparoscopic Pancreatic Tumor Enucleation

A prospective study of pancreatic duct stent in preventing post-ERCP pancreatitis of difficult bile duct cannulation

Application of Endoscopic Pancreatic Duct Stent Insertion: A Report of 20 cases

Laparoscopic resection of pancreatic neck tumor combined with pancreatic duct stenting

Comparative effectiveness research on small IT knife pre-cut and conventional guidewire cannulation on selective biliary intubation (with video)

Comparison between different advanced cannulation techniques for difficult biliary cannulation: a systematic review with a meta-analysis

Application of angiographic guidewire in intrahepatic bile duct super-selective intubation

Comparison of sequential pancreatic duct guidewire placement technique and needle knife precut sphincterotomy for difficult biliary cannulation.

Pancreatic duct stent preventing post endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients

Application of Needle-Knife in Difficult Biliary Cannulation for Endoscopic Retrograde Cholangiopancreatography.

Single-Operator Wire-Guided Cannulation Technique Enables Easier Cannulation of Endoscopic Retrograde Cholangiopancreatography

Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis

THE CLINICAL VALUE OF PANCREATIC STENTS IN THE TREATMENT OF CHRONIC PANCREATITIS

[A Prospective Randomized Controlled Trial of Pancreatic Duct Stent Internal Versus External Drainage with Pancreaticojejunostomy for the Early Curative Effect after Pancreaticoduodenectomy].